106 related articles for article (PubMed ID: 10383720)
21. Intraductal fibroadenoma under the nipple in an 11-year-old female.
Hayano F; Yamada S; Nakano S; Watanabe T; Sasaguri Y; Koga S
Diagn Pathol; 2014 Feb; 9():32. PubMed ID: 24512699
[TBL] [Abstract][Full Text] [Related]
22. Co-expression of tenascin and fibronectin in epithelial and stromal cells of benign lesions and ductal carcinomas in the human breast.
Yoshida T; Matsumoto E; Hanamura N; Kalembeyi I; Katsuta K; Ishihara A; Sakakura T
J Pathol; 1997 Aug; 182(4):421-8. PubMed ID: 9306963
[TBL] [Abstract][Full Text] [Related]
23. Study of the expression of Tn antigen in different types of human breast cancer cells using VVA-B4 lectin.
Konska G; Guerry M; Caldefie-Chezet F; De Latour M; Guillot J
Oncol Rep; 2006 Feb; 15(2):305-10. PubMed ID: 16391846
[TBL] [Abstract][Full Text] [Related]
24. Correlation of E-cadherin expression and routine immunohistochemistry panel in breast invasive ductal carcinoma.
Mohammadizadeh F; Ghasemibasir H; Rajabi P; Naimi A; Eftekhari A; Mesbah A
Cancer Biomark; 2009; 5(1):1-8. PubMed ID: 19242056
[TBL] [Abstract][Full Text] [Related]
25. Intraductal fibroadenoma and intraductal phyllodes tumour--a part of the spectrum of the breast ductal adenoma?
Bezić J
Virchows Arch; 2010 Jan; 456(1):105-6. PubMed ID: 20013344
[No Abstract] [Full Text] [Related]
26. [P21 expression of ras oncogene product in benign and malignant female mammary lesions].
Zhang JZ; Fan SC; Liu HF
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):302-3. PubMed ID: 7874767
[TBL] [Abstract][Full Text] [Related]
27. The coexistence of atypical intraductal hyperplasias with breast carcinoma.
Bogdan F; Gîrniţă L; Florescu M; Simionescu C; Crăiţoiu S; Comănescu V
Rom J Morphol Embryol; 1998; 44(1-4):65-71. PubMed ID: 15678845
[TBL] [Abstract][Full Text] [Related]
28. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach.
Flucke U; Flucke MT; Hoy L; Breuer E; Goebbels R; Rhiem K; Schmutzler R; Winzenried H; Braun M; Steiner S; Buettner R; Gevensleben H
Histopathology; 2010 Jun; 56(7):852-9. PubMed ID: 20636789
[TBL] [Abstract][Full Text] [Related]
29. New aspects in the histological diagnosis of breast carcinoma.
Shousha S
Semin Surg Oncol; 1996; 12(1):12-25. PubMed ID: 8821405
[TBL] [Abstract][Full Text] [Related]
30. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of E-cadherin, Ki-67 and lymphatic vessel invasion in abdominal metastases of human breast cancer.
Debald M; Kaiser C; Abramian A; Schildhaus HU; Locher P; Wolfgarten M; Kuhn W; Braun M
Anticancer Res; 2013 May; 33(5):1971-5. PubMed ID: 23645745
[TBL] [Abstract][Full Text] [Related]
32. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
33. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
34. Co-expressed peptide receptors in breast cancer as a molecular basis for in vivo multireceptor tumour targeting.
Reubi C; Gugger M; Waser B
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):855-62. PubMed ID: 12111125
[TBL] [Abstract][Full Text] [Related]
35. The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.
Koo JS; Jung W; Jeong J
Jpn J Clin Oncol; 2009 Sep; 39(9):560-8. PubMed ID: 19531543
[TBL] [Abstract][Full Text] [Related]
36. Expressional correlation of human epidermal growth factor receptor 2, estrogen/progesterone receptor and protein 53 in breast cancer.
Panahi M; Saki N; Ashourzadeh S; Rahim F
Asian Pac J Cancer Prev; 2013; 14(6):3699-703. PubMed ID: 23886168
[TBL] [Abstract][Full Text] [Related]
37. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
38. Immunoperoxidase localization and denovo biosynthesis of a 10.5-kDa inhibin in benign and malignant conditions of human breast.
Sheth AR; Chinoy RF; Garde SV; Panchal CJ; Sheth NA
Cancer Lett; 1993 Aug; 72(1-2):127-34. PubMed ID: 8402568
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
[TBL] [Abstract][Full Text] [Related]
40. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
